Indeed, Song et al. identified a IL1B+ macrophage cluster in patients with HBV/HCV-related HCC that might be involved in anti-tumour responses, although further experiments need to be conducted to confirm this statement [20]. This evidence concerns the gene IL1B and hepatocellular carcinoma.